CARL (Carlsmed) Common Stock: $0.00 Mil (As of Mar. 2026)


CARL Carlsmed Inc CARL
12 GF Score
Price $11.90
! 1 Warning Sign
View Full Analysis

What is Carlsmed Common Stock?

Carlsmed CARL -2.54% 12 Common Stock is $0.00 Mil as of Mar. 2026. GuruFocus rates CARL with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Carlsmed Common Stock Historical Data

* Premium members only.

The historical data trend for Carlsmed's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carlsmed Common Stock Chart

Carlsmed Annual Data
Trend Dec23 Dec24 Dec25
Common Stock
0.00 0.00 0.00

Carlsmed Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CARL
12GF Score
Carlsmed Inc CARL
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carlsmed Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
Carlsmed (CARL) has a Common Stock of $0.00 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Carlsmed and its competitors.
Is Carlsmed's Common Stock too high?
Carlsmed's current Common Stock is $0.00 Mil. Overall, Carlsmed has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Carlsmed's Common Stock compare to SLP and TBRG?
Carlsmed's Common Stock of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Carlsmed and its competitors. Carlsmed's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carlsmed stock overvalued right now?
Carlsmed (CARL) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Carlsmed's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Carlsmed (CARL), the current Common Stock is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carlsmed Business Description

Other Exchanges I82:Germany
Address 1800 Aston Avenue, Suite 100, Carlsbad, CA, USA, 92008
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
12GF Score

Get the complete analysis for CARL

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.90
Price